[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Nanomedicine Market Status and Outlook 2018-2025

August 2018 | 142 pages | ID: GE8FD696C72EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies
  • GE Healthcare
  • Johnson & Johnson
  • Mallinckrodt plc
  • Merck & Co. Inc.
  • Nanosphere Inc.
  • Pfizer Inc.
  • Sigma-Tau Pharmaceuticals Inc.
  • Smith & Nephew PLC
  • Stryker Corp
  • Teva Pharmaceutical Industries Ltd.
  • UCB (Union chimique belge) S.A
Market by Type
  • Regenerative Medicine
  • In-vitro & In-vivo Diagnostics
  • Vaccines
  • Drug Delivery
Market by Application
  • Clinical Cardiology
  • Urology
  • Genetics
  • Orthopedics
  • Ophthalmology
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Nanomedicine Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Regenerative Medicine
  3.1.2 In-vitro & In-vivo Diagnostics
  3.1.3 Vaccines
  3.1.4 Drug Delivery
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Clinical Cardiology
  4.1.2 Urology
  4.1.3 Genetics
  4.1.4 Orthopedics
  4.1.5 Ophthalmology
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Regenerative Medicine Production by Region
    6.1.1.2 In-vitro & In-vivo Diagnostics Production by Region
    6.1.1.3 Vaccines Production by Region
    6.1.1.4 Drug Delivery Production by Region
  6.1.2 Production by Application
    6.1.2.1 Clinical Cardiology Production by Region
    6.1.2.2 Urology Production by Region
    6.1.2.3 Genetics Production by Region
    6.1.2.4 Orthopedics Production by Region
    6.1.2.5 Ophthalmology Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Regenerative Medicine Demand by Region
    6.2.1.2 In-vitro & In-vivo Diagnostics Demand by Region
    6.2.1.3 Vaccines Demand by Region
    6.2.1.4 Drug Delivery Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Clinical Cardiology Demand by Region
    6.2.2.2 Urology Demand by Region
    6.2.2.3 Genetics Demand by Region
    6.2.2.4 Orthopedics Demand by Region
    6.2.2.5 Ophthalmology Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 GE Healthcare
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Johnson & Johnson
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Mallinckrodt plc
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Merck & Co. Inc.
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Nanosphere Inc.
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Pfizer Inc.
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Sigma-Tau Pharmaceuticals Inc.
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Smith & Nephew PLC
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Stryker Corp
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Teva Pharmaceutical Industries Ltd.
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 UCB (Union chimique belge) S.A

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Nanomedicine Industry Dynamics & Regulations List
Table Global Nanomedicine Sales Revenue, Cost and Margin, 2015-2018E
Table Global Nanomedicine Market Status by Type 2015-2018E, in USD Million
Table Global Nanomedicine Market Status by Application 2015-2018E, in USD Million
Table Global Nanomedicine Market Status by Application 2015-2018E, in Volume
Table Global Nanomedicine Market by Region 2015-2018E, in USD Million
Table Global Nanomedicine Market Share by Region in 2018, in USD Million
Table Global Nanomedicine Market by Region 2015-2018E, in Volume
Table Global Nanomedicine Market Share by Region in 2018, in Volume
Table Regenerative Medicine Production Value by Region 2015-2018E, in USD Million
Table Regenerative Medicine Production Volume by Region 2015-2018E, in Volume
Table In-vitro & In-vivo Diagnostics Production Value by Region 2015-2018E, in USD Million
Table In-vitro & In-vivo Diagnostics Production Volume by Region 2015-2018E, in Volume
Table Vaccines Production Value by Region 2015-2018E, in USD Million
Table Vaccines Production Volume by Region 2015-2018E, in Volume
Table Drug Delivery Production Value by Region 2015-2018E, in USD Million
Table Drug Delivery Production Volume by Region 2015-2018E, in Volume
Table Clinical Cardiology Production Value by Region 2015-2018E, in USD Million
Table Clinical Cardiology Production Volume by Region 2015-2018E, in Volume
Table Urology Production Value by Region 2015-2018E, in USD Million
Table Urology Production Volume by Region 2015-2018E, in Volume
Table Genetics Production Value by Region 2015-2018E, in USD Million
Table Genetics Production Volume by Region 2015-2018E, in Volume
Table Orthopedics Production Value by Region 2015-2018E, in USD Million
Table Orthopedics Production Volume by Region 2015-2018E, in Volume
Table Ophthalmology Production Value by Region 2015-2018E, in USD Million
Table Ophthalmology Production Volume by Region 2015-2018E, in Volume
Table Regenerative Medicine Market Size by Region 2015-2018E, in USD Million
Table Regenerative Medicine Market Size by Region 2015-2018E, in Volume
Table In-vitro & In-vivo Diagnostics Market Size by Region 2015-2018E, in USD Million
Table In-vitro & In-vivo Diagnostics Market Size by Region 2015-2018E, in Volume
Table Vaccines Market Size by Region 2015-2018E, in USD Million
Table Vaccines Market Size by Region 2015-2018E, in Volume
Table Drug Delivery Market Size by Region 2015-2018E, in USD Million
Table Drug Delivery Market Size by Region 2015-2018E, in Volume
Table Clinical Cardiology Market Size by Region 2015-2018E, in USD Million
Table Clinical Cardiology Market Size by Region 2015-2018E, in Volume
Table Urology Market Size by Region 2015-2018E, in USD Million
Table Urology Market Size by Region 2015-2018E, in Volume
Table Genetics Market Size by Region 2015-2018E, in USD Million
Table Genetics Market Size by Region 2015-2018E, in Volume
Table Orthopedics Market Size by Region 2015-2018E, in USD Million
Table Orthopedics Market Size by Region 2015-2018E, in Volume
Table Ophthalmology Market Size by Region 2015-2018E, in USD Million
Table Ophthalmology Market Size by Region 2015-2018E, in Volume
Table GlobalNanomedicine Forecast by Type 2019F-2025F, in USD Million
Table Nanomedicine Forecast by Type 2019F-2025F, in Volume
Table Nanomedicine Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Nanomedicine Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Nanomedicine Market Forecast by Region 2019F-2025F, in USD Million
Table Nanomedicine Market Forecast by Region 2019F-2025F, in Volume
Table GE Healthcare Information
Table Nanomedicine Sales, Cost, Margin of GE Healthcare
Table Johnson & Johnson Information
Table Nanomedicine Sales, Cost, Margin of Johnson & Johnson
Table Mallinckrodt plc Information
Table Nanomedicine Sales, Cost, Margin of Mallinckrodt plc
Table Merck & Co. Inc. Information
Table Nanomedicine Sales, Cost, Margin of Merck & Co. Inc.
Table Nanosphere Inc. Information
Table Nanomedicine Sales, Cost, Margin of Nanosphere Inc.
Table Pfizer Inc. Information
Table Nanomedicine Sales, Cost, Margin of Pfizer Inc.
Table Sigma-Tau Pharmaceuticals Inc. Information
Table Nanomedicine Sales, Cost, Margin of Sigma-Tau Pharmaceuticals Inc.
Table Smith & Nephew PLC Information
Table Nanomedicine Sales, Cost, Margin of Smith & Nephew PLC
Table Stryker Corp Information
Table Nanomedicine Sales, Cost, Margin of Stryker Corp
Table Teva Pharmaceutical Industries Ltd. Information
Table Nanomedicine Sales, Cost, Margin of Teva Pharmaceutical Industries Ltd.
Table UCB (Union chimique belge) S.A Information
Table Nanomedicine Sales, Cost, Margin of UCB (Union chimique belge) S.A
Table Global Nanomedicine Sales Revenue by Company 2015-2017, in USD Million
Table Global Nanomedicine Sales Volume by Company 2015-2017, in Volume
Table Global Nanomedicine Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Nanomedicine Picture
Figure Nanomedicine Industry Chain Diagram
Figure Global Nanomedicine Sales Revenue 2015-2018E, in USD Million
Figure Global Nanomedicine Sales Volume 2015-2018E, in Volume
Figure Global Nanomedicine Market Status by Type 2015-2018E, in Volume
Figure North America Nanomedicine Market Size and Growth 2015-2018E, in USD Million
Figure North America Nanomedicine Market Size and Growth 2015-2018E, in Volume
Figure Europe Nanomedicine Market Size and Growth 2015-2018E, in USD Million
Figure Europe Nanomedicine Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Nanomedicine Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Nanomedicine Market Size and Growth 2015-2018E, in Volume
Figure South America Nanomedicine Market Size and Growth 2015-2018E, in USD Million
Figure South America Nanomedicine Market Size and Growth 2015-2018E, in Volume
Figure Middle East Nanomedicine Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Nanomedicine Market Size and Growth 2015-2018E, in Volume
Figure Africa Nanomedicine Market Size and Growth 2015-2018E, in USD Million
Figure Africa Nanomedicine Market Size and Growth 2015-2018E, in Volume
Figure Global Nanomedicine Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Nanomedicine Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Nanomedicine Sales Price Forecast 2019F-2025F
Figure Global Nanomedicine Gross Margin Forecast 2019F-2025F
Figure Global Nanomedicine Sales Revenue by Company in 2018, in USD Million
Figure Global Nanomedicine Price by Company in 2018
Figure Global Nanomedicine Gross Margin by Company in 2018


More Publications